Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic
Non-pharmaceutical interventions implemented to mitigate COVID-19 transmission are likely to have impacted spread of other infectious diseases. Here, the authors investigate changes in the incidence of 31 notifiable infectious diseases using surveillance data from China.
Guardado en:
Autores principales: | Meng-Jie Geng, Hai-Yang Zhang, Lin-Jie Yu, Chen-Long Lv, Tao Wang, Tian-Le Che, Qiang Xu, Bao-Gui Jiang, Jin-Jin Chen, Simon I. Hay, Zhong-Jie Li, George F. Gao, Li-Ping Wang, Yang Yang, Li-Qun Fang, Wei Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/289219934cee4318b892ea1e138b6447 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Incidence of notified Lyme borreliosis in Germany, 2013–2017
por: Julia Enkelmann, et al.
Publicado: (2021) -
Enlightenment on oscillatory properties of 23 class B notifiable infectious diseases in the mainland of China from 2004 to 2020.
por: Chuanliang Han, et al.
Publicado: (2021) -
The changing pattern of enteric pathogen infections in China during the COVID-19 pandemic: a nation-wide observational study
por: Li-Ping Wang, et al.
Publicado: (2021) -
The Impact of the COVID-19 Pandemic on the Composition of Dietary Supplements and Functional Foods Notified in Poland
por: Kacper Wróbel, et al.
Publicado: (2021) -
Incidence of Arrhythmias and Their Prognostic Value in Patients With Multiple Myeloma
por: Yongxin Li, et al.
Publicado: (2021)